Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection

The prevalence of hepatitis C virus (HCV) infection in Asian countries is high. This study assessed the efficacy and safety of elbasvir/grazoprevir (EBR/GZR) in participants with HCV infection from Asia‐Pacific countries and Russia. In this phase 3, randomized, placebo‐controlled, double‐blind study...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hepatol Commun
Autori principali: George, Jacob, Burnevich, Eduard, Sheen, I‐Shyan, Heo, Jeong, Kinh, Nguyen Van, Tanwandee, Tawesak, Cheng, Pin‐Nan, Kim, Do Young, Tak, Won Young, Kizhlo, Svetlana, Zhdanov, Konstantin, Isakov, Vasily, Liang, Liwen, Lindore, Pauline, Ginanni, Joy, Nguyen, Bach‐Yen, Wahl, Janice, Barr, Eliav, Robertson, Michael, Ingravallo, Paul, Talwani, Rohit
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5944586/
https://ncbi.nlm.nih.gov/pubmed/29761174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1177
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi